The BRI offers a wide variety of internal funding opportunities. Since its inception in 2005, the BRI has supported the BWH research community with over $14MM in funding through a wide range of programs. In FY2018 alone, the BRI allocated $2.4MM to support research through various mechanisms including the Fund to Sustain Research Excellence (FSRE), which provides $50,000 bridge grants to support investigators whose R01 (or equivalent) was scored but not funded; the $100,000 BRIght Futures Prize, which is selected by public vote and awarded annually at Discover Brigham; the $500,000 BRI Directors Transformative Awards (BDTA), which are reviewed by the BRI’s external Scientific Advisory Board; the $50,000 Health & Technology Innovation Awards, which are selected through a “Shark Tank” style process involving BWH faculty (clinicians/researchers), donors, venture capitalists, representatives of the biopharma/device industry and other friends of the Brigham; as well as two new funding mechanisms, the BRI NextGen Awards and the BRI Pilot Awards, which support new research initiatives and projects with funds up to $50,000.
Each year, the BRI internal review committee nominates institutional candidates for several funding announcements in which the number of applicants from a given institution are restricted. For these prestigious awards, BWH will cover the minimum Indirect Cost Rate if not met by the terms of the award. Please note that the funding opportunities in this section are specific to awards that consider BWH a separate entity from HMS and are not part of the HMS Foundation Funds program.
PIVOT is a searchable database of funding opportunities. You will need to sign up (using your Partners or Harvard email address and selecting Harvard University as your institution when doing so) and then you can search for funding applications by a variety of parameters as well as sign up for alerts.